1 "systematic investigation of critical experimentalparameters. Nucleic Acids Res 2001" 29 : e65-5,
2 "andSmad4 in hepatocellular carcinoma. Int J Oncol 1999" 14 : 127-31,
3 "Vogelstein B. Purification of DNAfrom formaldehyde fixed and paraffin embedded humantissue. Biochem Biophys Res Commun 1985" 130 : 118-26,
4 "Vance J. Report of thesecond international workshop on human chromosome 1mapping 1995. Cytogenet Cell Genet 1996" 72 : 114-44,
5 "Transforming growth factor beta1 inhibits mouse keratinocytes late in G1 independent ofeffects on gene transcription. Cancer Res 1995" 1452-7,
6 "The transforming growth factor-beta signalingpathway in tumorigenesis. Curr Opin Oncol 2001" 70-7,
7 "Park JG. Promoter hypermethylation downregulatesRUNX3 gene expression in colorectal cancer celllines. Oncogene 2004" 6736-42,
8 "Park JG. 139 KCCR-affiliatedHospitals. 2002 annual report of the Korea central cancerregistry Based on registered data from 139 hospitals.Cancer Research and Treatment 2004" 36 : 103-14, 2004
9 "Miyaki M. Suppression of tumourigenicity in humancolon carcinoma cells by introduction of normal chromosome1p36 region. Oncogene 1993" 8 (8): 2253-8,
10 "Liu W-W. Hemizygous deletion and hypermethylationof RUNX3 gene in hepatocellular carcinoma.World J Gastroenterol 2004" 10 : 376-80,
1 "systematic investigation of critical experimentalparameters. Nucleic Acids Res 2001" 29 : e65-5,
2 "andSmad4 in hepatocellular carcinoma. Int J Oncol 1999" 14 : 127-31,
3 "Vogelstein B. Purification of DNAfrom formaldehyde fixed and paraffin embedded humantissue. Biochem Biophys Res Commun 1985" 130 : 118-26,
4 "Vance J. Report of thesecond international workshop on human chromosome 1mapping 1995. Cytogenet Cell Genet 1996" 72 : 114-44,
5 "Transforming growth factor beta1 inhibits mouse keratinocytes late in G1 independent ofeffects on gene transcription. Cancer Res 1995" 1452-7,
6 "The transforming growth factor-beta signalingpathway in tumorigenesis. Curr Opin Oncol 2001" 70-7,
7 "Park JG. Promoter hypermethylation downregulatesRUNX3 gene expression in colorectal cancer celllines. Oncogene 2004" 6736-42,
8 "Park JG. 139 KCCR-affiliatedHospitals. 2002 annual report of the Korea central cancerregistry Based on registered data from 139 hospitals.Cancer Research and Treatment 2004" 36 : 103-14, 2004
9 "Miyaki M. Suppression of tumourigenicity in humancolon carcinoma cells by introduction of normal chromosome1p36 region. Oncogene 1993" 8 (8): 2253-8,
10 "Liu W-W. Hemizygous deletion and hypermethylationof RUNX3 gene in hepatocellular carcinoma.World J Gastroenterol 2004" 10 : 376-80,
11 "LianJB. Integration of Runx and Smad regulatory signals attranscriptionally active subnuclear sites. Proc Natl Acad SciUSA 2002" 99 : 8048-53,
12 "Kreipe H. Quantitativeanalysis of promoter hypermethylation in laser-microdissectedarchival specimens. Lab Invest 2001" 635-7,
13 "Kern SE.DPC4 gene in various tumor types. Cancer Res 1996" Weinstein CL 2527-30,
14 "KangGH. Methylation of RUNX3 in various types of humancancers and premalignant stages of gastric carcinoma. LabInvest 2004" 84 : 479-84,
15 "Kang GH.Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.Am J Pathol 2003" 1371-78,
16 "Ito Y. Causal relationshipbetween the loss of RUNX3 expression and gastriccancer. Cell 2002" ya (ya): 113-24,
17 "Issa JP. CpG island methylator phenotypes in aging and cancer" Issa JP. CpG island methylator phenotypes inaging and cancer. Semin Cancer Biol 1999 9 : 349-57,
18 "Issa JP. CpG island methylator phenotype in colorectal cancer.Proc Natl Acad Sci USA 1999" 8681-6, 1999
19 "Hong SD. Inactivation patterns ofp16/INK4A in oral squamous cell carcinomas. Exp Mol Med2004" 165-71,
20 "Heldin C. Mechanisms ofTGF-beta signaling in regulation of cell growth anddifferentiation. Immunol Lett 2002" 85-91,
21 "Hagiwara K. Mutational analysis of the Smad6and Smad7 genes in hepatocellular carcinoma. Int J MolMed 2001" take (take): 49-52,
22 "Derynck R. Transcriptional regulation of the transforminggrowth factor-beta-inducible mouse germ line Igalpha constant region gene by functional corporation ofSmad" 16979-85,
23 "Chronic liver injury^TGF-β^cancer. Exp MolMed" 33 : 179-90, 2001
24 "Choi JK. Tumor suppressor activity of RUNX3. Oncogene2004" 4336-40,
25 "Chiba T. Frequentloss of RUNX3 gene expression in human bile duct andpancreatic cancer cell lines. Oncogene 2004" 2401-7,